Last reviewed · How we verify
BLI800
At a glance
| Generic name | BLI800 |
|---|---|
| Sponsor | Ipsen |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Safety Study of 3 Different Bowel Cleansing Preparations (PHASE3)
- An Open-Label Preference Evaluation of BLI800 (PHASE4)
- A Safety and Efficacy Study of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy (PHASE3)
- Efficacy, Safety and Tolerability of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy (PHASE2)
- Efficacy, Safety and Tolerability of a New Bowel Cleansing Preparation (BLI800) in Adult Subjects Undergoing Colonoscopy (PHASE3)
- Eziclen Drug Utilisation in Real Life Setting
- An Open Label Study to Assess the Effect of BLI800 on Safety and Clinical Chemistry Parameters (PHASE1,PHASE2)
- BLI800-303: An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |